Sectra AB header image

Sectra AB

SECT B

Equity

ISIN SE0022419784 / Valor 138742727

NASDAQ Nordic Exchange Stockholm, Equities (2025-11-21)
SEK 281.80+1.51%

Sectra AB
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Sectra AB is a Swedish company specializing in medical IT and cybersecurity solutions. With approximately 1,100 employees globally, the company focuses on developing and selling advanced technologies that cater to niche markets within these sectors. In the medical IT domain, Sectra provides systems that enhance the efficiency and effectiveness of healthcare services, such as picture archiving and communication systems (PACS) and other radiology and pathology solutions. In cybersecurity, Sectra offers secure communication systems and services designed to protect sensitive information for government and defense organizations. The company's commitment to innovation and specialized expertise positions it as a key player in both the healthcare and cybersecurity industries.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (21.11.2025):

Sectra AB — reporting on the fiscal year 2024/2025 and the fourth quarter (Feb–Apr) 2025 — delivered solid growth: record order bookings, higher net sales and materially stronger recurring and cloud revenues, while operating profit improved on an underlying basis (partly boosted by a one-off patent settlement). The Board proposes an ordinary dividend in line with last year and an extraordinary dividend. Management highlights continued progress in the transition to service deliveries, with some near-term headwinds from reduced license sales and major customer go‑lives.

Contracted order bookings

Fiscal year 2024/2025: +39.9% to SEK 8,706.1m (guaranteed SEK 7,653.0m). Q4 Feb–Apr 2025: +223.4% to SEK 2,900.3m (guaranteed SEK 2,382.1m). Of the guaranteed Q4 bookings, 7% were recognized as revenue in the quarter and a further 15–25% are expected to be recognized within 12 months.

Net sales and recurring revenue

FY net sales rose 9.3% to SEK 3,239.8m (10.2% on unadjusted FX). Recurring revenue for the year was SEK 2,067.4m (+19.9%); Cloud Recurring Revenue (CRR) up 48.9% to SEK 591.1m. Q4 net sales were SEK 914.1m (+1.8%); Q4 recurring revenue SEK 574.6m (+24.0%) and CRR SEK 184.1m (+61.8%).

Profitability

FY operating profit SEK 723.0m, which includes a SEK 110.0m positive effect from a patent settlement; comparable operating profit (underlying) SEK 613.0m (+18.4%) with an operating margin of 18.9% (vs 17.5). Q4 operating profit SEK 198.9m (+0.8%), margin 21.8% (22.0). Profit for the period: FY SEK 563.4m; Q4 SEK 131.2m.

Cash flow and shareholder returns

Cash flow from operations FY SEK 922.4m (vs SEK 326.3m prior year); Q4 cash flow SEK 222.3m. The Board proposes an ordinary dividend of SEK 1.10 per share (unchanged) and an extraordinary dividend of SEK 1.00 per share, reflecting the year’s cash generation and financial position.

Strategy and near‑term outlook

Management reports strong progress in shifting to service-based deliveries (medical diagnostic imaging as a service) and high customer satisfaction (record Best in KLAS results). Near term, lower license sales and profitability pressure from large customer go‑lives are expected, but the transition is seen as beneficial long term.

Presentation

The report will be presented by CEO Torbjörn Kronander and CFO Jessica Holmquist on June 5, 2025; a recording and live stream are available via Sectra’s investor site.

Summarized from source with an LLMView Source

Key figures

3.51%1Y
%3Y
%5Y

Performance

28.9%1Y
28.6%3Y
28.6%5Y

Volatility

Market cap

5297 M

Market cap (USD)

Daily traded volume (Shares)

92,777

Daily traded volume (Shares)

1 day high/low

278.95 / 272.85

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Vertex Inc
Vertex Inc Vertex Inc Valor: 55908112
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.33%USD 19.79
All for One Group SE
All for One Group SE All for One Group SE Valor: 192106
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.46%EUR 39.80
AIXTRON SE
AIXTRON SE AIXTRON SE Valor: 4566068
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.21%EUR 16.32
Procore Technologies Inc
Procore Technologies Inc Procore Technologies Inc Valor: 53026320
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.30%USD 71.09
Entegris Inc
Entegris Inc Entegris Inc Valor: 1102899
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
7.06%USD 73.66
Exact Sciences Corp
Exact Sciences Corp Exact Sciences Corp Valor: 1183218
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.23%USD 100.90
Lem Holding SA
Lem Holding SA Lem Holding SA Valor: 2242762
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.16%CHF 303.00
RxSight Inc
RxSight Inc RxSight Inc Valor: 112649019
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
13.41%USD 10.15
stock3 AG
stock3 AG stock3 AG Valor: 117302445
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.67%EUR 29.80
paragon GmbH & Co. KGaA
paragon GmbH & Co. KGaA paragon GmbH & Co. KGaA Valor: 1150842
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.33%EUR 2.17